New Imaging Technique For Early Diagnosis Of Alzheimer’s Disease

In a recent study, researchers from Australia developed an advanced imaging and blood screening techniques that can be used in early diagnosis of Alzheimer’s disease. The study was conducted by researchers from the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing (AIBL). They highlighted their study at the International Conference on Alzheimer's disease in Hawaii recently.

http://www.healthimaginghub.com/article/1654-new-imaging-technique-for-early-diagnosis-of-alzheimers-disease.html

CvergenX Acquires Global Rights Of InterveneXRT

CvergenX, Inc. and Moffitt Cancer Center announced that they have signed a licensing agreement, which includes CvergenX having the exclusive global rights of InterveneXRT. The latter is a technology platform that provides individualization of radiotherapy. InterveneXRT was developed by researchers from Moffitt Cancer Center.


http://www.healthimaginghub.com/article/1655-cvergenx-acquires-global-rights-of-intervenexrt.html